↓ Skip to main content

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, August 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Published in
Journal of Pharmaceutical Policy and Practice, August 2021
DOI 10.1186/s40545-021-00354-3
Pubmed ID
Authors

Yohhei Hamada

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 20%
Researcher 1 20%
Student > Master 1 20%
Unknown 2 40%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Nursing and Health Professions 1 20%
Social Sciences 1 20%
Unknown 2 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2021.
All research outputs
#20,710,927
of 23,310,485 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#414
of 423 outputs
Outputs of similar age
#357,458
of 432,420 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#21
of 21 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 423 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,420 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.